<div id="readability-page-1"><div> By Megan Cheah <pre></pre> Wuxi AppTec plans to raise around $1 billion by issuing U.S. dollar-settled zero coupon convertible bonds, as it seeks to boost its capacity and capabilities. The Shanghai-based company, which provides drug research, development and manufacturing services, plans to issue the bonds with a principal amount of 6.78 billion yuan, equivalent to $999 million, Wuxi AppTec said Friday. The bonds can be converted to Hong Kong-listed shares at an initial conversion price of 153 Hong Kong dollars per share, or $19.54, subject to adjustments and conditions, said the company, which is listed in both Shanghai and Hong Kong. The conversion price is a premium of around 18% over Wuxi AppTec's Thursday closing price of HK$130.10, the company said. Assuming full conversion of all the bonds at this price, the converted shares will represent around 9.1% of Wuxi's enlarged H-share capital and around 1.7% of its total issued share capital. Wuxi intends to use the net proceeds of around $1.02 billion for global capacity and capability expansion, and general corporate purposes. Morgan Stanley, Citigroup and Goldman Sachs are the banks advising Wuxi on its bond issuance. Wuxi AppTec's shares in Hong Kong closed 5.2% lower at HK$130.10 on Thursday, but are about 32% higher year to date. <pre></pre> Write to Megan Cheah at megan.cheah@wsj.com <pre></pre> (END) Dow Jones Newswires May 14, 2026 20:41 ET (00:41 GMT)Copyright (c) 2026 Dow Jones &amp; Company, Inc.</div></div>

药明康德

华夏恒生生物科技ETF(QDII)

易方达沪深300医药ETF

药明康德计划通过以美元结算的零息可转换债券筹集约 10 亿美元，以增强其产能和能力。这些债券可按初始价格 HK$153 转换为股份，约占扩大后 H 股资本的 9.1%。筹集的资金将用于全球扩展和公司用途。摩根士丹利、花旗集团和高盛正在为此次发行提供咨询

Wuxi AppTec to Raise Around $1 Billion Through Zero Coupon Convertible Bonds

MorningStar

华宝恒生港股通创新药精选ETF

汇添富国证港股通创新药ETF

易方达中证生物科技主题ETF

华夏中证生物科技主题ETF

华宝中证制药ETF

生物科技ETF基金

国泰中证生物医药ETF

华泰柏瑞恒生创新药ETF(QDII)

摩根士丹利

花旗

高盛

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

CITIGROUP INC 6.250 NON CUM SER II PFD WI

GS Hldg R

药明康德计划通过发行零息可转换债券筹集约 10 亿美元